Pınar, İ. E. Et Al. 2021. Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience. Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.5, no.1 , 1-8.

Pınar, İ. E., Özkocaman, V., Özkalemkaş, F., Ersal, T., Yalçın, C., Orhan, B., ... Candar, Ö.(2021). Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience. Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.5, no.1, 1-8.

Pınar, İbrahim Et Al. "Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience," Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.5, no.1, 1-8, 2021

Pınar, İbrahim E. Et Al. "Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience." Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.5, no.1, pp.1-8, 2021

Pınar, İ. E. Et Al. (2021) . "Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience." Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.5, no.1, pp.1-8.

@article{article, author={İbrahim Ethem Pınar Et Al. }, title={Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience}, journal={Uludağ Üniversitesi Tıp Fakültesi Dergisi}, year=2021, pages={1-8} }